ISMPP Highlights
Global Transparency Committee
With the evolving requirements and expectations for the pharmaceutical industry to increase its transparency related to clinical trial data, medical publication practices and financial disclosure, the need exists for ISMPP members to stay apprised of recent developments and current best practices for adoption by their companies. The ISMPP Global Transparency Committee…
ISMPP Shares Member Publications and Presentations
ISMPP is pleased to share these recent publications and presentations by members of the Society. The publication and presentation of research and information that report on publishing practices is necessary to advance the medical publications profession, and improve standards and best practices…
New Medical Writer Joint Position Statement Released by AMWA, EMWA, and ISMPP
The American Medical Writers Association (AMWA), European Medical Writers Association (EMWA), and International Society for Medical Publication Professionals (ISMPP) released a Joint Position Statement on the Role of Professional Medical Writers on January 17, 2017,...
Message from Our Leadership
Robert J. Matheis
ISMPP President and CEO
News and Trends
HEOR: Why It Is Changing the World of Medical Publications
Health economics and outcomes research (HEOR) has been the fastest-growing function in the pharmaceutical industry for a decade or more. Medical publication professionals are seeing publication plans increasingly populated by HEOR studies – particularly post-launch. While medical publication professionals are accustomed to working with…
Predatory Journals: Everyone’s Problem
The growing availability and marketing of “predatory journals” – fake or fraudulent journals with questionable or no quality control standards – raise challenges for the scientific community. It can be difficult to distinguish predatory journals from established journals, making it important for researchers, institutions, and medical publication professionals to know about their existence and practices…
Sunshine Act and 21st Century Cures Act: A Double-Take on a Complex Picture
Since the Physician Payments Sunshine Act (Sunshine Act) was enacted in 2010, questions about its provisions and ultimate impact on transparency have circulated among physicians, the pharmaceutical industry, and other stakeholders. Now, more than two years since the final rules for implementation of the Sunshine Act became effective…
What Would You Do?
In our role as medical publication professionals, we may occasionally encounter situations in which it is not obvious how to ensure good publication practice. Have you ever wished you could consult the ISMPP membership for guidance when these situations arise? Here’s your opportunity!
What Would You Do? is a section of The MAP that presents case scenarios as an educational tool for medical publication professionals. The section provides a case scenario to ponder, and readers are invited to participate in a poll by selecting one of the listed solutions. Readers can also submit their thoughts on the scenario anonymously. The poll results, plus educational insights, are posted in a later issue for readers to digest.
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
ISMPP (pronounced IzMap) is the only nonprofit organization founded by medical publication professionals for medical publication professionals